These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6356901)

  • 21. Labetalol compared with prindolol plus hydraliazine in the treatment of hypertension: a double-blind cross-over study.
    Barnett AJ; Kalowski S; Guest C
    Med J Aust; 1978 Jan; 1(2):105-9. PubMed ID: 349319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of labetalol and propranolol in hypertension.
    Nicholls DP; Husaini MH; Bulpitt CJ; Stephens MD; Butler AG
    Br J Clin Pharmacol; 1980 Mar; 9(3):233-7. PubMed ID: 6988003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Labetalol in general practice: a review.
    Kane JA
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):59S-63S. PubMed ID: 7093101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of labetalol in moderate to severe hypertension.
    Macdonald I; Hua AS; Thomas GW; Woo KT; Whitworth JA; Kincaid-Smith P
    Med J Aust; 1980 Apr; 1(7):325-7. PubMed ID: 7393061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experience with labetalol in hypertension.
    Bolli P; Waal-Manning J; Wood AJ; Simpson FO
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):765-71. PubMed ID: 791330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined alpha- and beta-adrenoceptor blockade with labetalol in hypertension.
    Frick MH; Pörsti P
    Br Med J; 1976 May; 1(6017):1046-8. PubMed ID: 773498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Labetalol and pindolol in the treatment of hypertension: a comparative study.
    Romo M; Halttunen P; Saarinen P; Sarna S
    Ann Clin Res; 1979 Dec; 11(6):249-52. PubMed ID: 398184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Labetalol in severe and resistant hypertension.
    Williams LC; Murphy MJ; Parsons V
    Br J Clin Pharmacol; 1979; 8(Suppl 2):143S-147S. PubMed ID: 526395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the combination of alpha- and beta-adrenoceptor blockade in hypertension.
    Stokes GS; Mennie BA; Gellatly R; Hill A
    Clin Pharmacol Ther; 1983 Nov; 34(5):576-82. PubMed ID: 6627819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of labetalol versus enalapril as monotherapy in elderly patients with hypertension: results of 24-hour ambulatory blood pressure monitoring.
    Applegate WB; Borhani N; DeQuattro V; Kaihlanen PM; Oishi S; Due DL; Sirgo MA
    Am J Med; 1991 Feb; 90(2):198-205. PubMed ID: 1996588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of hypertension with labetalol.
    Bolli P; Waal-Manning HJ; Simpson FO; Seeman HM
    N Z Med J; 1977 Dec; 86(602):557-63. PubMed ID: 306082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A long-term study of labetalol in general practice.
    Kane J; Gregg I; Stephens MD
    Br J Clin Pharmacol; 1979; 8(Suppl 2):167S-170S. PubMed ID: 118766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Labetalol, a new alpha- and beta-adrenoreceptor blocking agent, in hypertension.
    Hansson L; Hänel B
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):763-4. PubMed ID: 10952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Labetalol and bendrofluazide: comparison of their antihypertensive effects.
    Horvath JS; Caterson RJ; Collett P; Duggin GG; Kelly DH; Tiller DJ
    Med J Aust; 1979 Jun; 1(13):626-8. PubMed ID: 386062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Labetalol in resistant hypertension.
    Dargie HJ; Dollery CT; Daniel J
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):751-5. PubMed ID: 990154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW; Laugerotte A; Wright JM
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Labetalol in the treatment of hypertensive renal patients.
    Williams JG; De Voss K; Craswell PW
    Med J Aust; 1978 Feb; 1(4):225-8. PubMed ID: 26015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Labetalol.
    Carter BL
    Drug Intell Clin Pharm; 1983 Oct; 17(10):704-12. PubMed ID: 6354658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The anti-hypertensive efficacy of combined alpha- and beta-adrenoreceptor blockade with phentolamine-oxprenolol or with labetalol (AH 5158).
    Johnson BF; LaBrooy J; Munro-Faure AD
    Clin Sci Mol Med Suppl; 1976 Dec; 3():505s-507s. PubMed ID: 799558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effectiveness of labetalol compared to hydrochlorothiazide in hypertensive black patients.
    Lucas C; Jenkins P; Mendels J; Due D; Forbes WP; Sirgo MA
    J Natl Med Assoc; 1991 Oct; 83(10):866-71. PubMed ID: 1800760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.